Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in April 2026 (Volume 30, Issue 1) Submit manuscript

Non-invasive biomarkers and FIB-4, APRI scoring system to rule out advanced liver injury

Breadcrumb

  • Home
  • Non-invasive biomarkers and FIB-4, APRI scoring system to rule out advanced liver injury

Mohamed Hussein 1, *, Dina Mohamed 2 and Maha Ayman 3

1 Department of Biochemistry, Dubai Medical College, Dubai, United Arab Emirates.
2 Department of Parasitology, Dubai Medical College, Dubai, United Arab Emirates.
3 Department of Pathology, Dubai Medical College, Dubai, United Arab Emirates.
 
Research Article
World Journal of Advanced Research and Reviews, 2022, 13(03), 223-230
Article DOI: 10.30574/wjarr.2022.13.3.0198
DOI url: https://doi.org/10.30574/wjarr.2022.13.3.0198
 
Received on 25 January 2022; revised on 10 March 2022; accepted on 12 March 2022
 
Chronic liver Injury (CLI) and its end-stages, cirrhosis, and hepatocellular carcinoma (HCC), are leading causes of morbidity and mortality worldwide with enormous socioeconomic costs. Clinical management of chronic liver injury is dependent on the extent of liver fibrosis. Liver biopsy, the gold standard, is still recommended in most patients. Liver disease diagnosis can generally be made using a carefully obtained history, physical examination, and a few laboratory tests. Initial laboratory testing should include aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and total bilirubin. Biomarkers are being developed as alternatives to liver biopsy for predicting liver fibrosis, Cirrhosis and HCC in patients with chronic liver injury. An intensive research on non-invasive alternatives. A simple, reproducible, low-cost, and non-invasive tool that can follow the evolution of the disease overtime would be beneficial for the testing physician and is desired by the patients. The aim of this review is to summarize Non-Invasive Biomarkers in addition to score systems like FIB-4 and (Aspartate Platelet Ratio Index) APRI in assessment of Fibrosis, Cirrhosis and HCC.
 
Chronic liver Injury; HCC; Fibrosis; Cirrhosis
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2022-0198.pdf

Preview Article PDF

Mohamed Hussein, Dina Mohamed and Maha Ayman. Non-invasive biomarkers and FIB-4, APRI scoring system to rule out advanced liver injury. World Journal of Advanced Research and Reviews, 2022, 13(3), 223-230. Article DOI: https://doi.org/10.30574/wjarr.2022.13.3.0198

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution